Trading Signals: BCRX Stock Price Prediction and Forecast (Tue. Sep. 2, 2003 - Wed. Sep. 27, 2023)(BioCryst Pharmaceuticals, Inc.)
| BCRX latest price $7.3900 (0.82%) ($7.2000 - $7.4800) on Mon. May. 20, 2019. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.24% (three month average) | RSI | 52 | Latest Price | $7.3900(0.82%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | BCRX declines -0.5% a day on average for past five trading days. | Weekly Trend | BCRX declines -0.2% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support BCRX advance at 0% a week (0% probability) UUP(7%) XLC(4%) BLOK(2%) TBT(2%) VXX(2%) | Factors Impacting BCRX price | BCRX will decline at least -1.62% in a week (0% probabilities). SLV(-12%) SIL(-9%) GLD(-8%) GDXJ(-8%) GDX(-8%) | | | | | Relative Volatility | | | | Market Trend Strength | -1.62% (StdDev 3.24%) | Hourly BBV | 0 () | Intraday Trend | 1.4% | | | |
|
1 - 5 Day Possible Target | $0.72(-90.26%) | Resistance Level | $7.72 | 5 Day Moving Average | $7.61(-2.89%) | 10 Day Moving Average | $7.7(-4.03%) | 20 Day Moving Average | $7.72(-4.27%) | To recent high | -19.2% | To recent low | 1.5% | Market Cap | $1.304b | | | | BioCryst Pharmaceuticals, Inc. designs and develops novel, oral and small-molecule medicines. Its drug candidates include Berotralstat, BCX9930, BCX9250, RAPIVAB, ALPIVAB, RAPIACTA, PERAMIFLU, Galidesivir and Mundesine. The company was founded in 1986 and is headquartered in Durham, NC. |